Literature DB >> 9726824

Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization.

S A Vinores1, C C Chan, M A Vinores, D M Matteson, Y S Chen, D A Klein, A Shi, H Ozaki, P A Campochiaro.   

Abstract

Experimental autoimmune uveoretinitis (EAU) was induced in Lewis rats and B10.A mice by immunization with S-antigen (S-Ag) to study the potential roles of vascular endothelial growth factor (VEGF) and the beta1 and beta2 isoforms of transforming growth factor (TGFbeta1 and TGFbeta2) during the progression of the disease. VEGF has been implicated as an angiogenic factor in ischemic retinopathies; however, Lewis rats developing EAU have high levels of VEGF in the retina, but no neovascularization. In the present study, immunohistochemical staining for VEGF, TGFbeta1 and TGFbeta2 was performed on the retinas of Lewis rats developing EAU or with oxygen-induced ischemic retinopathy. In rats immunized with S-antigen, a marked upregulation of VEGF was immunohistochemically visualized from the inner nuclear layer to the inner limiting membrane prior to blood-retinal barrier (BRB) failure and lymphocytic infiltration. VEGF is normally induced by hypoxia and its induction leads to neovascularization. Coincident with the increase in VEGF, there was increased immunoreactivity for TGFbeta1 and TGFbeta2 within the same layers of the retina. In contrast, rats with ischemic retinopathy and retinal neovascularization showed only a modest increase in VEGF immunoreactivity, which is largely confined to retinal ganglion cells and inner retinal vessels, and little or no increase in TGFbeta1 or TGFbeta2. In addition, in mice developing EAU, which does not have an abrupt onset as it does in rats and may involve neovascularization, a comparable upregulation of VEGF in the inner retina to that seen in rats developing EAU occurs with no increase in TGFbeta1 or TGFbeta2. Since TGFbeta can inhibit endothelial cell proliferation, it is likely that an increase in TGFbeta may prevent VEGF from exerting its endothelial growth activity in the rat EAU model, but VEGF may be operative in inducing BRB failure. These data suggest that there is a complex interaction among growth factors in the retina and that retinal neovascularization may require an imbalance between stimulatory and inhibitory factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726824     DOI: 10.1016/s0165-5728(98)00075-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Aqueous humor IL-8, IL-10, and VEGF levels in Fuchs' uveitis syndrome and Behçet's uveitis.

Authors:  Mert Simsek; Pinar Cakar Ozdal; Filiz Akbiyik; Mehmet Citirik; Nilufer Berker; Yasemin Ozdamar Erol; Pelin Yilmazbas
Journal:  Int Ophthalmol       Date:  2019-05-07       Impact factor: 2.031

Review 3.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.

Authors:  S A Vinores; N L Derevjanik; H Ozaki; N Okamoto; P A Campochiaro
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

4.  Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry.

Authors:  Stefanie M Hauck; Johannes Dietter; Roxane L Kramer; Florian Hofmaier; Johanna K Zipplies; Barbara Amann; Annette Feuchtinger; Cornelia A Deeg; Marius Ueffing
Journal:  Mol Cell Proteomics       Date:  2010-07-04       Impact factor: 5.911

Review 5.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

6.  Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity.

Authors:  Raul Velez-Montoya; Carmen Clapp; Jose Carlos Rivera; Gerardo Garcia-Aguirre; Virgilio Morales-Cantón; Jans Fromow-Guerra; Jose Luis Guerrero-Naranjo; Hugo Quiroz-Mercado
Journal:  Clin Ophthalmol       Date:  2010-09-07

7.  Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.

Authors:  Piergiorgio Neri; Cesare Mariotti; Luca Cimino; Lucia Mercanti; Alfonso Giovannini
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

Review 8.  Ocular complications of childhood rheumatic diseases: uveitis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.686

9.  Structural and functional changes of the human macula during acute exposure to high altitude.

Authors:  M Dominik Fischer; Gabriel Willmann; Andreas Schatz; Kai Schommer; Ahmad Zhour; Eberhart Zrenner; Karl U Bartz-Schmidt; Florian Gekeler
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

10.  A Study of Various Histopathological Features and their Relevance in Pathogenesis of Psoriasis.

Authors:  Nikhil Moorchung; Js Khullar; Ns Mani; Manas Chatterjee; Biju Vasudevan; Tanu Tripathi
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.